Adjuvant therapy in non-small cell lung cancer: is targeted therapy joining the standard of care? Review

Gabay, Carolina, Russo, Alessandro, Raez, Luis E et al. (2021). Adjuvant therapy in non-small cell lung cancer: is targeted therapy joining the standard of care? . Expert Review of Anticancer Therapy, 21(11), 1229-1235. 10.1080/14737140.2021.1982387

International Collaboration

cited authors

  • Gabay, Carolina; Russo, Alessandro; Raez, Luis E; Rolfo Cervetto, Christian

sustainable development goals

authors

publication date

  • November 2, 2021

published in

keywords

  • ASSOCIATION
  • CHEMOTHERAPY
  • EGFR
  • Life Sciences & Biomedicine
  • METAANALYSES
  • NSCLC
  • OSIMERTINIB
  • Oncology
  • RADIOTHERAPY
  • RESECTED STAGE-IB
  • SURVIVAL
  • Science & Technology
  • VINORELBINE PLUS CISPLATIN
  • adjuvant therapy
  • erlotinib
  • gefitinib
  • osimertinib
  • tyrosine kinase inhibitor

Digital Object Identifier (DOI)

start page

  • 1229

end page

  • 1235

volume

  • 21

issue

  • 11